Increasing evidence suggests that certain types of cancers are more common in people with diabetes mellitus (DM). This study aimed to investigate the risk of skin cancer in patients with DM in Taiwan. In this retrospective cohort study using data from the Taiwan Longitudinal Health Insurance Research Database, the risk of developing overall skin cancer, including nonmelanoma skin cancer (NMSC) and melanoma, was compared by Poisson regression analysis and Cox regression analysis between the DM and non-DM cohorts. The DM cohort with newly diagnosed DM (n = 41,898) and a non-DM cohort were one-to-one matched by age, sex, index date, and comorbidities (coronary artery disease, hyperlipidemia, hypertension, chronic kidney disease, chronic obstructive pulmonary disease, and obesity). Compared with non-DM cohort statistically, for the people with DM aged ≥60 years, the incidence rates of overall skin cancer and NMSC were significantly higher (overall: DM/non-DM: number [n] = 99/76, incidence rate ratio [IRR] = 1.44, P = 0.02; NMSC: DM/non-DM: n = 94/66, IRR = 1.57, P = 0.005). By Cox regression analysis, the risk of developing overall skin cancer or NMSC was significantly higher after adjusting for sex, comorbidities, and overall diseases with immunosuppression status (overall: adjusted hazard ratio [AHR] = 1.46, P = 0.01; NMSC: AHR = 1.6, P = 0.003). Other significant risk factors were older males for skin cancer (overall: AHR = 1.68, P = 0.001; NMSC: AHR = 1.59, P = 0.004; melanoma: AHR = 3.25, P = 0.04), chronic obstructive pulmonary disease for NMSC (AHR = 1.44, P = 0.04), and coronary artery disease for melanoma (AHR = 4.22, P = 0.01). The risk of developing melanoma was lower in the DM cohort than in the non-DM cohort, but without significance (AHR = 0.56, P = 0.28; DM/ non-DM: n = 5/10). The incidence rate and risk of developing overall skin cancer, including NMSC, was significantly higher in older adults with DM. Other significant risk factors for older adults with DM were males for NMSC and melanoma, chronic obstructive pulmonary disease for NMSC, and coronary artery disease for melanoma.
Introduction
The increased risk of certain types of cancer in people with diabetes mellitus (DM) has been reported, including cancer of the liver, biliary tract, pancreas, stomach, colorectum, kidney, bladder, breast, and endometrium, but conversely a decreased risk of prostate cancer. [1, 2] Continuous hyperglycemia and high serum levels of insulin or insulin-like growth factor (IGF) have been proposed to be possible mechanisms for the carcinogenesis in DM patients. Persistent hyperglycemia may contribute to malignant cells growth, and the overproduction of superoxide and reactive oxygen species. [3] IGF modulates the epidermal cells proliferation. High serum levels of insulin and IGFs in DM patients have been shown to increase cellular proliferation and activation of the oncogenic epidermal growth factor receptors, resulting in mitogenic and antiapoptotic effects and inducing malignant cell transformation. [3] [4] [5] [6] The major categories of skin cancer include melanoma and nonmelanoma skin cancer (NMSC) (squamous cell carcinoma, basal cell carcinoma, and malignant neoplasm of sebaceous glands and sweat glands). These were among the top 10 most common types of cancers in Taiwan. [7] [8] [9] However, the risk of skin cancer in patients with DM has seldom been explored. Epidemiological studies in other countries have demonstrated inconsistent associations between type 2 DM and malignant melanoma or NMSC, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] with only a few reports about the association of NMSC and DM. [13, [15] [16] [17] The aim of this study was to investigate the risk of overall skin cancers, NMSC, and melanoma among a DM cohort and non-DM cohort with no history of skin cancer after controlling for confounding factors, including age, sex, comorbidities, and overall diseases with immunosuppression status using data from National Health Insurance Research Database (NHIRD).
Methods

Data sources
The National Health Insurance (NHI) program in Taiwan is a compulsory, single-payer, tax-financed healthcare system that was launched in 1995 and provides health care to 99% of the country's 23.75 million people. [21] It comprises information of demographic data, dates of clinical visits, and diagnostic codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM codes) of the beneficiaries, and it has contractual agreements with 97% of the hospitals and clinics in Taiwan. This database has been the source of many epidemiological studies published in peer-reviewed journals. [7, 9, [22] [23] [24] In this study, the Longitudinal Health Insurance Database 2000 (LHID2000) was used, which contains all of the original claims data of one million individuals randomly sampled from the registry for beneficiaries of the NHIRD from 1996 to 2000. No significant differences in the age and sex distribution have been shown between the patients in the LHID2000 and the original NHIRD. The randomly sampled one million beneficiaries were enrolled from 2000 and followed up until the end of 2012. The NHIRD contains de-identified data to ensure patient anonymity. The Institutional Review Board of Kaohsiung Veterans General Hospital approved this study.
Design
The ICD-9-CM codes were used to define diagnosis of diseases, comorbidities, and overall diseases with immunosuppression status in this study, as shown in Table 1 . This retrospective population-based cohort study was conducted with 2 study groups: a DM cohort and a comparison cohort without DM Table 1 ICD-9-CM codes used for diseases diagnosis and ATC codes for immunosuppressant in the this study. In all, 41,898 patients were identified as newly diagnosed DM from 2000 to 2005 after excluding those aged <18 years (n = 353), those with a diagnosis of skin cancer before the index date of DM patients (n = 41), and those who had incomplete NHI information (n = 1505). The comparison non-DM cohort was 1-to-1 matched with the DM cohort by age, sex, index date, and comorbidities with a minimum 2 visits. [23] The comorbidities included coronary artery disease (CAD) (410-414, A270, and NHIRD Randomly-sampled one million beneficiaries enrolled in 2000 (N=1,000,000) Table 1 . The overall diseases with immunosuppression status was based on a minimum of 3 visits from outpatient claim dataset or once admission from inpatient hospital claim dataset for those diseases in Table 1 , using immunosuppressive therapy at 3 visits for the autoimmune diseases or any organ transplantation, malignant neoplasm under 3 times chemotherapy or radiation therapy, acquired immunodeficiency syndrome, and immunodeficiency in 1 year duration before the index date of DM in this study (in DM/ non-DM cohort: n = 252/214). The Taiwan NHI Bureau regularly reviews the diagnoses in the NHIRD to maintain consistency at every referral teaching hospital and medical center. This study is retrospective because all the data had been collected before this study was conducted; however, this study would predict future outcomes. To determine the incidence of skin caner, each patient was assessed from the index date until the end of follow-up on December 31, 2012, or until the patient was censored because of death.
Diagnosis
Statistical analysis
Descriptive statistical analyses using Pearson chi-square tests were performed to compare the differences of the incidence of skin cancer between the DM and non-DM cohorts. The distribution of overall diseases with immunosuppression status in DM and non-DM cohorts was also compared by Pearson chisquare tests. The incidence rate (IR) was calculated as the incident number of skin cancer identified during follow-up, divided by the total person-years for each cohort, and stratified analysis by NMSC, melanoma, and subgroups of sex and age. The incidence rate ratio (IRR) of skin cancer between 2 cohorts was compared using Poisson regression analysis. The risk of developing skin cancer (the hazard of overall skin cancer, NMSC, or melanoma) in the 2 cohorts in age subgroups were calculated using Cox proportional-hazards regression univariate analysis, and adjustment for comorbidities and overall diseases with immunosuppression status was calculated by Cox regression multivariate analysis. Differences between the survival curves of cumulative incidences in the 2 cohorts were determined by using KaplanMeier survival analysis and the log-rank test.
Data extraction from the LHID2000 was performed by SAS version 9.4 (SAS Institute Inc., Cary, NC). IBM SPSS statistical software version 20 (IBM Institute Inc, NY) was used for all analyses. Statistics significance was set at a 2-tailed P value of less than 0.05.
Results
The DM and non-DM cohorts had comparable demographic characteristics and comorbidities as these factors were matched in the study design ( Table 2 ). The number of overall skin cancer was 119 in the DM cohort and 107 in the non-DM cohort from 2000 to 2005. The mean age (±SD, range) in the 2 cohorts at the diagnosis of skin cancer was 57.41 (±14.1, 18.1-105.6) years, with a male-to-female ratio of 1.04:1. The mean intervals between the index date and the occurrence of skin cancer were 5.7 ± 3.24 years for the DM cohort and 5.66 ± 2.79 years for the non-DM cohort. There were no statistically significant differ- Table 2 Demographic characteristics, comorbidities, and skin cancer of the DM and non-DM cohorts.
Characteristics
DM cohort (n = 41,898) n (%) Non-DM cohort (n = 41,898) n (%) P Overall skin cancer included non-melanoma skin cancer and melanoma. DM = diabetes mellitus, NA = nonapplicable, NMSC = nonmelanoma skin cancer, SD = standard deviation. * Overall immunosuppression status: including acquired immunodeficiency syndrome, immunodeficiency, autoimmune diseases with immunosuppressant, all major malignant neoplasms with chemotherapy or radiation therapy, organ transplantation with immunosuppressants. P < 0.05 was set for 2-tailed statistics significance. P value was estimated by Pearson chi-square test.
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Medicine ences in the mean interval from the index date to the occurrence of overall skin cancer, NMSC, and melanoma between the 2 cohorts, respectively. The IRRs of overall skin cancer, NMSC, and melanoma between the DM and non-DM cohorts, and stratified analysis by the subgroup of age and sex are presented in Table 3 . By the end of the follow-up, the IR of overall skin cancer was 3.2 per 10,000 person-years in the DM cohort, which was 1.18 times higher than in the non-DM cohort (IRR = 1.18, P = 0.22). The IR of NMSC was 3.04 per 10,000 person-years in the DM cohort, which was 1.29 times higher than in the non-DM cohort with borderline significance. (IRR = 1.29, P = 0.07). The IR of melanoma was 0.16 per 10,000 person-years in the DM cohort, which was 0.46 times lower than in the non-DM cohort, but without significance (IRR = 0.46, P = 0.11).
In the statistical analysis stratified by age or sex subgroup, those aged ≥60 years in the DM cohort had a significantly higher IR of overall skin cancers than the non-DM cohort. (IRR = 1.44, 95% confidence interval [CI] 1.07-1.94, P = 0.02; DM/non-DM: n = 99/76). The IR of NMSC was 1.57 times higher in the DM cohort than that in the non-DM cohort, which was statistically significant. (IRR = 1.57, 95% CI 1.15-2.15, P = 0.005; DM/non-DM: n = 94/66). For those aged <60 years, the IRs of overall skin cancer and NMSC were not significantly different between the 2 cohorts, respectively.
In age subgroup analysis, the IRRs of melanoma were not significantly different between the 2 cohorts. In sex subgroup analysis, IRRs of overall skin cancers, NMSC, or melanoma were also not significantly different between the 2 cohorts, respectively.
To investigate the potential risk factors for skin cancer in the age subgroups, Cox proportional-hazard regression analysis was performed, including DM status, sex, comorbidities, and overall diseases with immunosuppression status (Table 4) . KaplanMeier analysis was also performed for cumulative incidence of skin cancer (Figs. 2 and 3) .
In the subgroup of those aged ≥60 years, the risk of developing overall skin cancer was 1.46 times higher in the DM cohort than in the non-DM cohort after adjusting for sex, comorbidities, and overall diseases with immunosuppression status. (Adjusted hazard ratio [AHR] 1.46, 95% CI 1.09-1.97, P = 0.01) The DM cohort had a 60% increase of NMSC than in the non-DM cohort after adjusting for sex, comorbidities, and overall diseases with immunosuppression status. (AHR 1.6, 95% CI 1.17-2.19, P = 0.003) during follow-up period, and the difference was statistically significant. The hazard of melanoma in the DM cohort was 0.56 times lower in the DM cohort than in the non-DM cohort, but this difference did not reach significance, even after adjusting for sex, comorbidities, and overall diseases with immunosuppression status (AHR 0.56, 95% CI 0.19-1.63, P = 0.28). In the subgroup of age <60 years, there were no significant differences in any of these factors.
Other significant risks factors for developing skin cancer included sex, COPD, and CAD. The risk of developing overall skin cancer, NMSC, and melanoma was significantly higher in the older male patients than in the older female patients, respectively, after adjustment for DM, comorbidities, and overall diseases with immunosuppression status (in those age ≥60 years: overall: AHR 1.68, 95% CI 1.24-2.27, P = 0.001; NMSC: AHR 1.59, 95% CI 1.16-2.18, P = 0.004; melanoma: AHR 3.25, 95% CI 1.03-10.27, P = 0.04). In addition, the risk of developing NMSC was significantly higher in patients with COPD than in those without COPD (age ≥60 years: AHR 1.44, 95% CI 1.02-2.03, P = 0.04). Furthermore, the risk of developing melanoma was significantly higher in the patients with CAD than those without CAD (age ≥60 years: AHR 4.22, 95% CI 1.38-12.92, P = 0.01). Table 3 The incidence rate ratios of skin cancer in the DM and non-DM cohorts by age and sex subgroups.
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However, there were no statistically significant differences in the distribution of overall diseases with immunosuppression status between DM and non-DM cohorts (Table 2) , even in age subgroups. In addition, in age subgroups, the risk of developing overall skin cancer and NMSC was not significantly higher in patients with overall diseases with immunosuppression status than in those without immunosuppression status, even after adjustments (data not shown).
Kaplan-Meier analysis showed that there was statistically significant difference between 2 curves of the cumulative incidence of overall skin cancer or NMSC in 2 cohorts in those aged ≥60 years (log-rank test: overall: P = 0.01; NMSC: P = 0.004) (Figs. 2C and 3C) . DM cohort had a lower cumulative IR of melanoma compared with the non-DM cohort in those aged ≥60 years, but the difference did not reach statistical significance (log-rank test P = 0.27).
Discussion
In this study, compared with the non-DM cohort, in the subgroup of those aged ≥60 years, the IRRs of overall skin cancers or NMSC were significantly higher in the DM cohort. By Cox Figure 2 . Kaplan-Meier survival curves of overall skin cancer after index date of DM. A, Comparison of cumulative incidence of overall skin cancer in all patients with and without DM. B, In subgroup of age <60 years, comparison of cumulative incidence of overall skin cancer of patients with and without DM. C, In subgroup of age ≥60 years, comparison of cumulative incidence of overall skin cancer in patients with and without DM. Each patient was assessed from the index date until the end of the follow-up on December 31, 2012, or until the patient was censored because of death. com regression analysis, the risk of developing overall skin cancer or NMSC was significantly higher in the DM cohort after adjusting for sex, comorbidities, and overall diseases with immunosuppression status. Other significant risk factors for older adults with DM were males for skin cancer (overall, NMSC, and melanoma), COPD for NMSC, and CAD for melanoma. The IRRs or risk of melanoma were lower in the DM cohort in both age and sex subgroups or after adjustments, although without significance, which could be related to the small number. In this study, the average incidence of DM in each year from age 18 to 105 was 0.7% from 2000 to 2005, which is similar to the study by Jiang et al. [22] In Taiwan, skin cancer has been among the 10 leading cancers in males or females since 2000. [7] [8] [9] The IR in this study is similar to the age-standardized IR of NMSC in the Taiwan cancer registry from 2000 to 2006 (7.3: males 7.81, females 6.78) per 100,000 people and those of melanoma (0.67: males 0.70, females 0.63) per 100,000 people. [9] The male-to-female ratio in this cohort was 1.04:1, which is similar to the Taiwan cancer registry database (male: female = 1.1:1). [8] In USA, the IR of melanoma was exceeding 22 cases over 100,000 people. [25, 26] According to the consensus report by the American Diabetes Association, [1] the relationship between diabetes and cancer was discussed with regard to 4 major aspects. First was the association between diabetes and the incidence of cancer. [1] Previous studies have reported inconsistent associations between DM and Medicine malignant melanoma or NMSC, with some articles reporting a higher, [10] [11] [12] [13] [14] and others a lower IRR [15, 17, 19] of melanoma in patients with DM than reference populations with or without significance. Hemminki et al [13] reported that the incidence ratios of cutaneous squamous cell carcinoma was higher in patients with type 2 DM. However, other studies have reported a significantly lower rate ratio of NMSC in people with DM. [15, 16] Differences in ethnicity or environmental factors may be related to these discrepancies.
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Second was risk factors for both diabetes and cancer. [1] Shared common risks factors, diabetes itself, or metabolic dysfunction could all increase the risk for some types of cancer. However, it is difficult to evaluate these factors because of inter-relationship. [1] Some studies have reported that the lifestyle risk factors for the development of DM, [27, 28] such as obesity and occupational physical inactivity, were also related to an increased risk of melanoma. [29, 30] Chronic exposure to sun or ultraviolet ray is also an important risk factor for skin cancer. [31] [32] [33] In addition, occupations that were male predominant and involved chronic exposure to the sun, such as farm workers, fisherman, and construction laborers, have also been reported to carry a higher risk for skin cancer. [34] [35] [36] [37] Other possibly associated risk factors for skin cancer include lifestyle, physical activity, and environmental factors.
The possible mechanism of the association between NMSC and COPD may be environmental exposure to chemicals, such as polycyclic aromatic hydrocarbons (PAH). Tobacco smoke and air pollution are also major risk factors for COPD patients, both of which contain PAH that are potential human carcinogens. [38] Occupational or environmental exposure of PAH has also been reported to increase the risk for squamous cell carcinoma of the skin. [39, 40] The possible mechanism of the association of melanoma and CAD may be insulin resistance. Insulin resistance is an additional risk factor for the pathogenesis of cardiovascular disease in patients with type 2 DM, [41] and it has been proposed to be a potentially independent risk factor for melanoma. [42] Further studies are needed to elucidate these hypotheses.
Immunosuppression status is a potential risk factor for skin cancer. The associated diseases mentioned in the literatures and previous studies were organ transplantation with long-term immunosuppressive therapy (corticosteroids, azathioprine, and cyclosporine), [43, 44] leukemia and lymphoma, [45, 46] and acquired immunodeficiency syndrome. [47, 48] The autoimmune diseases with immunosuppressive therapy, such as rheumatoid arthritis, ulcerative colitis, or inflammatory bowel disease, were also reported to be associated with skin cancer. [49] [50] [51] In this study, the immunosuppression status was not present to be a risk factor for overall skin cancer, NMSC, and melanoma. The probable causes were the complexity of the diseases with immunosuppression status, the low incidence of those diseases, and the extremely limited number of skin cancer in the diseases with immunosuppression status. Therefore, it was hard to obtain statistically significant results.
Third was possible physiological links between diabetes and the risk for cancer. [1] In vitro studies have shown that human keratinocytes irradiated with ultraviolet B light undergo premature stress-induced senescence or apoptosis, [32, 52] and that this response to ultraviolet B irradiation is dependent on the functional activation of the IGF receptor. [53] The IGF system is an integral part of growth regulation by the body, and abnormalities at all levels of the IGF system have been implicated in carcinogenesis and cellular transformation. [54] [55] [56] The regulation between the IGF system and melanoma cells have been investigated in several articles. Abnormality in insulin binding and receptor phosphorylation were found in an insulin-resistant melanoma cell line. [57] The resistance to apoptosis in melanoma cells has been shown to be promoted by IGF1 through an increased expression of antiapoptosis proteins (BCL2, BCL-X(L), and Survivin). [58] The long-term effect of hyperinsulinemia was another possible mechanism of the cancer development in patients with DM. [59] Hyperglycemia may increase the production of reactive oxygen species, [60] decrease the expression of antioxidants, [61] lead to DNA damage, [62] and promote cancer cells proliferation. [63] Fourth was the influences of diabetes treatment on the risk for cancer. [1] The medication of DM may have a role on the risk for skin cancer. Using insulin or rosiglitazone had been reported to possibly reduce the incidence of NMSC in DM patients. [24, 64] Due to the complexity of multidrug regimens and the effect of the duration and cumulative dosage of diabetes medication, the effect of diabetes treatment was not considered in this study.
There are still many unanswered questions with regards to these 4 aspects, and why the different direction of IRRs of NMSC and melanoma between the DM and non-DM cohorts in this study is unclear. Further studies were warranted to clarify this issue.
The major strengths of the present study are the large study population from the Taiwan's NHIRD, the chronological relationship from the cohort study, the method of 1:1 matching by age, sex, and comorbidities for the patients in both cohorts, and analysis by subgroup stratification and confounders adjustment. This increases the statistical power for the evaluation of the risk in the analyses. Nevertheless, there were some limitations to this study. Even though the study population included one million people, and searching for more skin cancer over a 6-year period, the total number of skin cancer in the DM cohort, and especially those with melanoma, was still low. In addition, several factors were not available from the insurance claims data, including body mass index, details of smoking, and alcohol consumption, [65] laboratory data, occupation, and physical activity. For example, data on several suspected risk factors for skin cancer, such as chronic exposure to sunlight or ultraviolet ray, occupation, and obesity were lacking. Furthermore, the misclassification may exist because a certain proportion of patients with DM, skin cancer, or obesity may have been undiagnosed. The factor of DM treatment should try to be included in the future studies. However, the lack of those factors might have resulted in some degree of bias. Generalizability of this study may be limited due to above reasons, environmental factors, or ethnicity.
Conclusions
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